Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation - Fierce Biotech

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation Fierce Biotech Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines Business Wire Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom Reuters Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion CNBC Pfizer strikes up to $10.5B deal with Chinese biotech Innovent Axios